£490.00

It has never been this cheap. We have no record of a lower price.

£490 today · cheaper than every other day in the last 3 months

Anti-Rejection Drugs and Immunosuppressants Liver Study

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 20 days · 20 data points (no recent data)

Historical
Generating forecast…
£490.00 £465.50 £475.30 £485.10 £494.90 £504.70 £514.50 11 August 2026 15 August 2026 20 August 2026 25 August 2026 30 August 2026
View at Amazon ↗

Price data last checked 71 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 20 days • 1 price levels

Days at Price
20 days 0 5 10 15 20 £490 Days at Price

Price Analysis

Most common price: £490 (20 days, 100.0%)

Price range: £490 - £490

Price levels: 1 different prices over 20 days

Description

This comprehensive study provides a detailed outlook for anti-rejection drugs and immunosuppressants used in liver disease treatments from 2023 to 2028. It focuses on the United States, offering specific data across various states and zip codes to identify market opportunities. The report calculates latent demand, also known as potential industry earnings (P.I.E.), in millions of U.S. dollars. By analyzing 10,833 zip codes, the study delivers precise statistical benchmarks. Users can view the percent share each zip code holds in relation to its state and the entire United States. This comparative data allows for quick assessments of specific geographic areas, making it a useful resource for understanding market distribution and demand patterns for liver disease treatments.

Key Features

Provides a detailed market outlook for anti-rejection drugs and immunosuppressants for liver diseases from 2023 to 2028.

Includes latent demand estimates, or potential industry earnings (P.I.E.), measured in millions of U.S. dollars.

Covers extensive geographic data across 10,833 specific zip codes throughout the United States.

Offers comparative benchmarks by reporting the percent share of each zip code relative to its state and the country.

Delivers statistical insights into the United States market for liver disease treatment drugs.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
09 January 2023
Listed Since
26 January 2023

Similar Products You Might Like

The 2023-2028 Outlook for Anti-Rejection Drugs and Immunosuppressants for Liver Diseases Treatments in Japan
99% match

The 2023-2028 Outlook for Anti-Rejection Drugs and Immunosuppressants for Liver Diseases Treatments in Japan

£495.00 19 Sep 2026
US Anti-Rejection Drugs & Immunosuppressants Liver Study
99% match

US Anti-Rejection Drugs & Immunosuppressants Liver Study

£520.00 06 Nov 2026
World Outlook: Anti-Rejection Drugs for Liver Diseases
98% match

World Outlook: Anti-Rejection Drugs for Liver Diseases

Price unavailable
US Liver Cirrhosis Drug Market Outlook 2023-2028 Report
97% match

US Liver Cirrhosis Drug Market Outlook 2023-2028 Report

£490.00 30 Aug 2026
The 2023-2028 Outlook for Liver Health Supplements for US Zip Codes
97% match

The 2023-2028 Outlook for Liver Health Supplements for US Zip Codes

£490.00 31 Aug 2026
The 2021-2026 World Outlook for Liver Disease Treatments
97% match

The 2021-2026 World Outlook for Liver Disease Treatments

£795.00 31 Oct 2026
The 2023-2028 Outlook for Liver Cirrhosis Drugs in China
97% match

The 2023-2028 Outlook for Liver Cirrhosis Drugs in China

£495.00 09 Nov 2026
World Outlook for Liver Disease Treatments 2025-2030
97% match

World Outlook for Liver Disease Treatments 2025-2030

Price unavailable
The 2023-2028 Outlook for Liver Health Supplements in Japan
97% match

The 2023-2028 Outlook for Liver Health Supplements in Japan

£495.00 03 Sep 2026
India Liver Cirrhosis Drugs Market Outlook 2023-2028 Study
97% match

India Liver Cirrhosis Drugs Market Outlook 2023-2028 Study

£515.00 05 Nov 2026
The 2023-2028 Outlook for Liver Health Supplements in China
97% match

The 2023-2028 Outlook for Liver Health Supplements in China

£495.00 27 Aug 2026
The 2025-2030 World Outlook for Liver Cirrhosis Drugs
96% match

The 2025-2030 World Outlook for Liver Cirrhosis Drugs

Price unavailable
The 2023-2028 Outlook for Liver Health Supplements in India
96% match

The 2023-2028 Outlook for Liver Health Supplements in India

£515.00 03 Sep 2026
The 2023-2028 Outlook for Liver Health Supplements in the United States
96% match

The 2023-2028 Outlook for Liver Health Supplements in the United States

£520.00 03 Sep 2026
The 2016-2021 Outlook for Liver Cancer Drugs in Japan
96% match

The 2016-2021 Outlook for Liver Cancer Drugs in Japan

£595.00 27 Aug 2026
US Liver Cancer Drug Outlook 2016-2021 Econometric Study
96% match

US Liver Cancer Drug Outlook 2016-2021 Econometric Study

£595.00 01 Nov 2026
US Targeted Therapy Liver Cancer Drug Outlook 2023-2028
96% match

US Targeted Therapy Liver Cancer Drug Outlook 2023-2028

£490.00 07 Nov 2026
Chronic Liver Disease: From Molecular Biology to Therapy (Hepatology Research and Clinical Developments)
96% match

Chronic Liver Disease: From Molecular Biology to Therapy (Hepatology Research and Clinical Developments)

£252.99 27 Aug 2026
Targeted Therapy Liver Cancer Drugs Outlook 2023-2028
96% match

Targeted Therapy Liver Cancer Drugs Outlook 2023-2028

£520.00 06 Nov 2026
The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in Japan
95% match

The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in Japan

£495.00 05 Nov 2026
World Outlook for Liver Organs-on-Chips 2025-2030 Report
95% match

World Outlook for Liver Organs-on-Chips 2025-2030 Report

Price unavailable
The 2016 Report on Liver Cancer Drugs: World Market Segmentation by City
95% match

The 2016 Report on Liver Cancer Drugs: World Market Segmentation by City

£995.00 29 Oct 2026
The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in China
95% match

The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in China

£495.00 06 Nov 2026
The 2023-2028 World Outlook for Organ Transplant Rejection Medications
95% match

The 2023-2028 World Outlook for Organ Transplant Rejection Medications

£795.00 12 Sep 2026